Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > How was this resolved?

<< Previous

Bullboard Posts

Next >>

Comment by Snowballgrowthon Dec 29, 2020 11:49pm

90 Views

Post# 32195062

RE:RE:RE:RE:RE:RE:RE:RE:How was this resolved?

Benedict16th wrote: You could have one billion Dollars of sales and earn zero, it is all about the margings of profits. Not much profits to be made out of generics these days. It is up to black Kinights to spell it out. Is it not?

Here we go to the value. It is all about the strategic platform, get growth and free cash flows from operations.

I added more today at 5.30-5.32.

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland